Dr. Joshua D. Palmer, MD
Claim this profileOhio State University Comprehensive Cancer Center
Studies Brain Tumor
Studies Uterine Tumors
7 reported clinical trials
10 drugs studied
Area of expertise
1Brain Tumor
Stage IV
ALK positive
2Uterine Tumors
Stage IV
Affiliated Hospitals
Clinical Trials Joshua D. Palmer, MD is currently running
Surgery and Radiation vs. Radiation Alone
for Brain Cancer
This phase III trial compares the usual treatment of surgery after stereotactic radiosurgery (SRS) to receiving SRS before surgery in treating patients with cancer that has spread to the brain (brain metastases). Stereotactic radiosurgery is a type of radiation therapy that delivers a high dose of radiation to target tumors and minimizes effect on normal surrounding brain tissue. The combination of surgery and radiation may stop the tumor from growing for a few months or longer and may reduce symptoms of brain metastases. This study investigates whether treating with SRS before surgery may be better than SRS after surgery in reducing the possibility of the tumor coming back, reducing or preventing the cancer from spreading to other areas of the brain and reducing the risk of scarring on the brain from radiation.
Recruiting2 awards Phase 3
DaRT Seeds
for Skin Cancer
This is a multi-center clinical study enrolling up to 86 participants. The primary objectives are to determine the objective response rate (ORR) established by the confirmed best overall response (BOR) following intratumoral administration of DaRT - Diffusing Alpha-Emitters Radiation Therapy, as well as to assess the Duration of Response (DOR) 6 months from initial response. Secondary objectives are to assess the safety of DaRT, and to assess the progression free survival (PFS), overall survival (OS), Overall Duration of Response (O-DOR), local control and quality of life (QOL) for patients treated with DaRT.
Recruiting1 award N/A24 criteria
More about Joshua D. Palmer, MD
Clinical Trial Related2 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Joshua D. Palmer, MD has experience with
- Stereotactic Radiosurgery
- Trametinib
- Whole-Brain Radiotherapy
- Alectinib
- Neuropsychological Evaluation And Intervention
- Optune-Tumor Treating Fields (TTFields) Therapy
Breakdown of trials Joshua D. Palmer, MD has run
Brain Tumor
Uterine Tumors
Brain Metastasis
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Joshua D. Palmer, MD specialize in?
Joshua D. Palmer, MD focuses on Brain Tumor and Uterine Tumors. In particular, much of their work with Brain Tumor has involved Stage IV patients, or patients who are ALK positive.
Is Joshua D. Palmer, MD currently recruiting for clinical trials?
Yes, Joshua D. Palmer, MD is currently recruiting for 4 clinical trials in Columbus Ohio. If you're interested in participating, you should apply.
Are there any treatments that Joshua D. Palmer, MD has studied deeply?
Yes, Joshua D. Palmer, MD has studied treatments such as Stereotactic Radiosurgery, Trametinib, Whole-Brain Radiotherapy.
What is the best way to schedule an appointment with Joshua D. Palmer, MD?
Apply for one of the trials that Joshua D. Palmer, MD is conducting.
What is the office address of Joshua D. Palmer, MD?
The office of Joshua D. Palmer, MD is located at: Ohio State University Comprehensive Cancer Center, Columbus, Ohio 43210 United States. This is the address for their practice at the Ohio State University Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.